Log in

Relevant bibliographies by topics / Dimeglumine gadopentetate

Contents

Journal articles
Dissertations / Theses
Books
Book chapters

Academic literature on the topic 'Dimeglumine gadopentetate'

Author: Grafiati

Published: 3 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dimeglumine gadopentetate.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dimeglumine gadopentetate"

1

Liang, Zonghui, Lin Ma, Dehang Wang, et al. "Efficacy and Safety of Gadobutrol (1.0 M) versus Gadopentetate Dimeglumine (.5 M) for Enhanced Mri of Cns Lesions: A Phase Iii, Multicenter, Single-blind, Randomized Study in Chinese Patients." Magnetic Resonance Insights 5 (January 2012): MRI.S9348. http://dx.doi.org/10.4137/mri.s9348.

Full text

Abstract:

The aim of this study was to compare the efficacy and safety of macrocyclic gadobutrol (1.0 M) with linear gadopentetate dimeglumine (0.5 M) for contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions in Chinese patients (N = 147) with known or suspected CNS lesions, who were enrolled in this single-blind, randomized, parallel-group study. Three blinded independent readers evaluated all efficacy variables. The primary efficacy variable was the difference between the two agents for the change in contrast-to-noise ratio (CNR) between non-enhanced and contrast-e

APA, Harvard, Vancouver, ISO, and other styles

2

Christodoulou, Panagiotis, Panagiotis G. Doxas, Chariton E. Papadakis, Panos Prassopoulos, Thomas Maris, and Emmanuel S. Helidonis. "Transtympanic Iontophoresis of Gadopentetate Dimeglumine: Preliminary Results." Otolaryngology–Head and Neck Surgery 129, no. 4 (2003): 408–13. http://dx.doi.org/10.1016/s0194-59980300713-7.

Full text

Abstract:

OBJECTIVE: We sought to demonstrate the feasibility of using iontophoresis to deliver pharmaceutical agents into the middle and inner ear for the treatment of middle and inner ear diseases, which is proved in this study by the successful iontophoresis of the ferromagnetic contrast agent gadopentetate dimeglumine. STUDY DESIGN AND SETTING: Eight rabbits were iontophoresed using gadopentetate dimeglumine solution 469 mg/mL. Then, all rabbits underwent magnetic resonance imaging for the detection of gadopentetate dimeglumine in the middle and inner ear structures. The study was conducted in the t

APA, Harvard, Vancouver, ISO, and other styles

3

Peters, J. L., and D. D. Shaw. "Hemodynamic Effects of Gadodiamide Injection and Gadopentetate Dimeglumine in Anesthetized Dogs." Acta Radiologica 34, no. 5 (1993): 510–16. http://dx.doi.org/10.1177/028418519303400518.

Full text

Abstract:

A nonionic (gadodiamide injection) and an ionic (gadopentetate dimeglumine) contrast medium were compared for their effect on hemodynamics in the anesthetized, open-chest dog. Both agents were administered i.v. over 15 s at dosages of 1.0 and 1.5 mmol/kg, in randomized order. Both contrast agents resulted in transient but statistically significant decreases in aortic pressure, left ventricular pressure, indices of left ventricular contractility and relaxation, and systemic and pulmonary vascular resistance, and increases in aortic blood flow. At each dosage investigated, the changes associated

APA, Harvard, Vancouver, ISO, and other styles

4

Besa, Cecilia, Suguru Kakite, Nancy Cooper, Marcelo Facciuto, and Bachir Taouli. "Comparison of gadoxetic acid and gadopentetate dimeglumine-enhanced MRI for HCC detection: prospective crossover study at 3 T." Acta Radiologica Open 4, no. 2 (2015): 204798161456128. http://dx.doi.org/10.1177/2047981614561285.

Full text

Abstract:

Background Gadoxetic acid and gadopentetate dimeglumine are gadolinium-based contrast agents (GBCAs) with an established role in HCC detection and characterization. Purpose To compare gadopentetate dimeglumine and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for image quality and hepatocellular carcinoma (HCC) detection/conspicuity. Material and Methods In this IRB approved cross-over pilot prospective study, 12 patients (all men; mean age, 56 years) with chronic liver disease at risk of HCC underwent two repeat MRI examinations using gadopentetate dimeglumine and gadoxetic acid (m

APA, Harvard, Vancouver, ISO, and other styles

5

Hald, J. K., I. O. Skalpe, S. J. Bakke, and P. H. Nakstad. "MR Imaging of Pituitary Region Lesions with Gadodiamide Injection." Acta Radiologica 35, no. 1 (1994): 65–69. http://dx.doi.org/10.1177/028418519403500114.

Full text

Abstract:

Twelve patients with known or suspected pituitary lesions underwent MR imaging with gadodiamide injection at a dose of 0.1 (n = 5) or 0.3 (n = 7) mM/kg. Six of the patients were also studied with 0.1 mM/kg gadopentetate dimeglumine. Consistent with previous reports gadodiamide injection was found to be a safe and effective contrast medium for MR imaging of the pituitary region. No additional diagnostic information was obtained using 0.3 mM/kg gadodiamide injection compared to 0.1 mM/kg gadopentetate dimeglumine in the same patients. The high dose (0.3 mM/kg) gadodiamide injection in 7 patients

APA, Harvard, Vancouver, ISO, and other styles

6

Myhr, G., P. A. Rinck, and A. Børseth. "Gadodiamide Injection and Gadopentetate Dimeglumine." Acta Radiologica 33, no. 5 (1992): 405–9. http://dx.doi.org/10.1177/028418519203300504.

Full text

Abstract:

A double-blind, randomized parallel phase III study in MR imaging of the central nervous system was conducted to compare the safety and diagnostic utility of gadodiamide injection and gadopentetate dimeglumine at a dose of 0.1 mmol/kg b.w. in 60 adult patients. Seven patients in the gadodiamide injection group experienced 10 adverse events, 5 of the events possibly related to the contrast agent. In the gadopentetate dimeglumine group 5 patients reported 3 contrast agent-related adverse events out of 8 events. All events were transient and required no treatment. Seven incidents of patient disco

APA, Harvard, Vancouver, ISO, and other styles

7

Vala, Vahedian Boroujeni 1. Hadi Hejazinia 2. Seyed Esmaeil Sadat Ebrahimi 1. 3. Morteza Pirali Hamedani 3. and Mehdi Shafiee Ardestani 1. 2. *. "MINIMIZING TOXICITY AND IMPROVING CELL UPTAKE OF DIMEGLUMINE GADOPENTETATE USING A NEW NON-TOXIC AND BIOCOMPATIBLE CHITOSAN-CARBON QUANTUM DOT HYBRID NANOGEL IN HEK293 AND MCF7 CELL LINES." Journal of Pharma Research 7, no. 7 (2018): 153–59. https://doi.org/10.5281/zenodo.1318314.

Full text

Abstract:

<strong><em>ABSTRACT</em></strong> <strong><em>M</em></strong><em>agnetic resonance imaging (MRI) contrast agents have been used routinely for more than 20 years in order to increase sensitivity and specificity of lesion detection. Gadolinium contrast media are chemical substances used in MRI scans. dimeglumine gadopentetate is one of the gadolinium-based MRI contrast agents. Gadolinium based Contrast agents (CAs) show significantly toxicity profiles. Recently, a delayed serious adverse reaction known as nephrogenic systemic fibrosis (NSF) has been reported in patients, with a marked reduction

APA, Harvard, Vancouver, ISO, and other styles

8

Muthurajan, Thenmozhi, Pooja Rammanohar, Nisha Palanisamy Rajendran, Swaminathan Sethuraman, and Uma Maheswari Krishnan. "Evaluation of a quercetin–gadolinium complex as an efficient positive contrast enhancer for magnetic resonance imaging." RSC Advances 5, no. 106 (2015): 86967–79. http://dx.doi.org/10.1039/c5ra16405b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Radhakrishnan, Rupa, Shamima Ahmed, Joshua Cole Tilden, and Humberto Morales. "Comparison of normal facial nerve enhancement at 3T MRI using gadobutrol and gadopentetate dimeglumine." Neuroradiology Journal 30, no. 6 (2017): 554–60. http://dx.doi.org/10.1177/1971400917719714.

Full text

Abstract:

Background and purpose The facial nerve is unique among cranial nerves in demonstrating normal enhancement of particular segments. The effect of varying T1 relaxivities of gadolinium-based contrast agents on facial nerve enhancement is unclear. In this study, we assess differences in normal facial nerve enhancement with two different gadolinium-based contrast agents, gadobutrol and gadopentetate dimeglumine. In addition, we evaluate differences in facial nerve enhancement with spin-echo (SE) T1 versus 3D inversion recovery prepared fast spoiled gradient-echo (FSPGR) post-contrast sequences. Me

APA, Harvard, Vancouver, ISO, and other styles

10

Myhr, G., P. A. Rinck, and A. Børseth. "Gadodiamide injection and gadopentetate dimeglumine." Acta Radiologica 33, no. 5 (1992): 405–9. http://dx.doi.org/10.3109/02841859209172022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Dimeglumine gadopentetate"

1

MASSON, BRUNO. "Etude randomisee en double aveugle omniscan* versus magnevist* au cours d'un examen i. R. M. Des conduits auditifs internes." Clermont-Ferrand 1, 1994. http://www.theses.fr/1994CLF1MS15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wang, Shuangqing [Verfasser]. "Increased Retention of Gadolinium in the Inflamed Brain after repeated administration of gadopentetate dimeglumine : A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF / Shuangqing Wang." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2020. http://d-nb.info/1223927385/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Dimeglumine gadopentetate"

1

Heck, Katherina. Intraindividueller äquimolarer Vergleich des makrozyklischen 1,0-molaren Gadolinium Chelats Gadobutrol mit dem 0,5-molaren Gadopentetat Dimeglumin für die abdomienelle dynamische Magnetresonanzangiographie. s.n.], 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Dimeglumine gadopentetate"

1

Youssef, H., M. Kuhn, G. Hammer, L. Meis, T. Burk, and T. Pencek. "Phase III multicenter evaluation of high-dose gadoteridol in neurologic pathology: comparison of 0.1 mmol/kg gadopentetate dimeglumine and 0.3 mmol/kg gadoteridol in patients with lesions of the central nervous system." In Proceedings of the XV Symposium Neuroradiologicum. Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79434-6_260.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Higer, H. P., M. Just, M. Grigat, et al. "Gadolinium-Dimeglumin-Gadopentetat im Vergleich mit der CPMG-Sequenz und der Bildsynthese." In Digitale bildgebende Verfahren Interventionelle Verfahren Integrierte digitale Radiologie. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73134-1_111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

"Gadopentetate Dimeglumine." In Hale’s Medications & Mothers’ Milk™ 2019. Springer Publishing Company, 2018. http://dx.doi.org/10.1891/9780826150356.0447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!